/PRNewswire/ Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer,.
Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter s High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay.